Cidara Therapeutics Inc
CDTX
Market Cap$632.67M
Close$
$26.14
46.4% downside
Current Fair Value
46.4% downsideOvervalued by 46.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $632.67 Million |
|---|---|
| Enterprise Value | $487.92 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-26.75 |
| Beta | 0.8 |
| Outstanding Shares | 14,177,743 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.83 |
|---|---|
| PEG | -3 |
| Price to Sales | - |
| Price to Book Ratio | 5.42 |
| Enterprise Value to Revenue | 1615.62 |
| Enterprise Value to EBIT | -4.52 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cidara Therapeutics Inc
CEO: Jeffrey Stein